Cellid Co Valuation Multiples

Cellid Co is valued at $42M as of November 2026, a 8.3x revenue multiple. In the last fiscal year, Cellid Co revenue was $7M and Cellid Co EBITDA was ($7M).

Cellid Co Overview

About Cellid Co

Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.


Founded

2006

HQ

South Korea

Employees

N/A

Financials (Last FY)

Revenue: $7M
EBITDA: ($7M)

EV

$54M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cellid Co Financials

Cellid Co reported last fiscal year revenue of $7M and negative EBITDA of ($7M).

In the same fiscal year, Cellid Co generated $1M in gross profit, ($7M) in EBITDA losses, and had net loss of ($9M).


Cellid Co P&L

In the most recent fiscal year, Cellid Co reported revenue of $7M and EBITDA of ($7M).

Cellid Co is unprofitable as of last fiscal year, with gross margin of 18%, EBITDA margin of (110%), and net margin of (137%).

See analyst estimates for Cellid Co
Last FY2025202620272028
Revenue$7M$7M
Gross Profit$1M$1M
Gross Margin18%18%
EBITDA($7M)($7M)
EBITDA Margin(110%)(110%)
EBIT Margin(128%)(128%)
Net Profit($9M)($9M)
Net Margin(137%)(137%)
Net Debt$4M-

Financial data powered by Morningstar, Inc.

Cellid Co Stock Performance

Cellid Co has current market cap of $42M, and enterprise value of $54M.

Market Cap Evolution


Cellid Co's stock price is $1.36.

Cellid Co share price decreased by 3.4% in the last 30 days.

Cellid Co has an EPS (earnings per share) of $-0.29.

See more trading valuation data for Cellid Co
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$54M$42M-0.1%-3.4%--$-0.29

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cellid Co Valuation Multiples

Cellid Co trades at 8.3x EV/Revenue multiple, and (7.5x) EV/EBITDA.

See NTM and 2027E valuation multiples for Cellid Co

Cellid Co Financial Valuation Multiples

As of November 8, 2026, Cellid Co has market cap of $42M and EV of $54M.

Cellid Co has a P/E ratio of (4.7x).

Last FY2025202620272028
EV/Revenue8.3x8.3x
EV/EBITDA(7.5x)(7.5x)
EV/EBIT(6.4x)(6.4x)
EV/Gross Profit46.4x46.4x
P/E(4.7x)(4.7x)
EV/FCF(2.1x)(2.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cellid Co Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cellid Co Margins & Growth Rates

In the most recent fiscal year, Cellid Co reported gross margin of 18%, EBITDA margin of (110%), and net margin of (137%).

See estimated margins and future growth rates for Cellid Co

Cellid Co Margins

Last FY2025202720282029
Gross Margin18%18%
EBITDA Margin(110%)(110%)
EBIT Margin(128%)(128%)
Net Margin(137%)(137%)
FCF Margin(403%)(403%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Cellid Co Operational KPIs

Access forward-looking KPIs for Cellid Co
Last FY2025202620272028
S&M Expenses to Revenue25%25%
G&A Expenses to Revenue15%15%
R&D Expenses to Revenue45%45%
Opex to Revenue146%146%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cellid Co Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all Cellid Co competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cellid Co

When was Cellid Co founded?Cellid Co was founded in 2006.
Where is Cellid Co headquartered?Cellid Co is headquartered in South Korea.
Is Cellid Co publicly listed?Yes, Cellid Co is a public company listed on Korea Exchange.
What is the stock symbol of Cellid Co?Cellid Co trades under 299660 ticker.
When did Cellid Co go public?Cellid Co went public in 2019.
Who are competitors of Cellid Co?Cellid Co main competitors include
What is the current market cap of Cellid Co?Cellid Co's current market cap is $42M.
What is the current revenue of Cellid Co?Cellid Co's last fiscal year revenue is $7M.
What is the current EV/Revenue multiple of Cellid Co?Current revenue multiple of Cellid Co is 8.3x.
Is Cellid Co profitable?No, Cellid Co is not profitable.
How many companies Cellid Co has acquired to date?Cellid Co hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cellid Co has invested to date?Cellid Co hasn't invested in any companies yet (or none have been disclosed publicly).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial